Is hyperoxia in early pediatric veno-veno extracorporeal life support associated with mortality?

Open Access

Table 3

New morbidity and unfavorable functional outcome for overall survivors who required VV-ECLS stratified by PaO₂ levels into hyperoxia and non-hyperoxia groups based on functional status scale change from admission to discharge.

ECLS group	Overall cohort of survivors (n = 81)	Non-hyperoxia group PaO₂ ≤ 122 (n = 70)	Hyperoxia group PaO₂ > 122 mmHg (n = 11)	p-value
New morbidity (change in FSS ≥ 3 points)	22 (27.2%)	20 (28.6%)	2 (18.2%)	0.471
Unfavorable outcome (change in FSS ≥ 5 points)	6 (7.4%)	5 (7.1%)	1 (9.1%)	0.819

FSS Subscale scores range from 1 to 5. Total scores are the sum of subscale scores ranging from 6 to 30. FSS: Functional Status Scale; ECLS: Extracorporeal Life Support.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.